Gossamer Bio (GOSS) Income towards Parent Company (2022 - 2025)
Historic Income towards Parent Company for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$48.2 million.
- Gossamer Bio's Income towards Parent Company fell 5654.64% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year decrease of 11324.01%. This contributed to the annual value of -$56.5 million for FY2024, which is 6856.36% up from last year.
- Gossamer Bio's Income towards Parent Company amounted to -$48.2 million in Q3 2025, which was down 5654.64% from -$38.3 million recorded in Q2 2025.
- Over the past 5 years, Gossamer Bio's Income towards Parent Company peaked at $49.2 million during Q2 2024, and registered a low of -$59.0 million during Q3 2022.
- Its 4-year average for Income towards Parent Company is -$39.8 million, with a median of -$44.7 million in 2024.
- In the last 5 years, Gossamer Bio's Income towards Parent Company skyrocketed by 21585.09% in 2024 and then crashed by 17774.01% in 2025.
- Gossamer Bio's Income towards Parent Company (Quarter) stood at -$57.2 million in 2022, then rose by 15.85% to -$48.1 million in 2023, then surged by 31.4% to -$33.0 million in 2024, then tumbled by 46.0% to -$48.2 million in 2025.
- Its Income towards Parent Company stands at -$48.2 million for Q3 2025, versus -$38.3 million for Q2 2025 and -$39.3 million for Q1 2025.